Isabelle de Monestrol

Publications
CV
Public outreach and news

Articles

Article: BMC NURSING. 2025;24(1):127
Lived experiences for individuals with cystic fibrosis who have undergone lung transplantation: a qualitative study
Skogeland U; de Monestrol I; Pincikova T; Godskesen T
Article: JOURNAL OF MEDICAL ECONOMICS. 2024;27(1):897-906
Clinical, economic, and societal burden of cystic fibrosis and the impact of the CFTR modulator, lumacaftor/ivacaftor: an assessment using linked registry data in Sweden
Lindblad A; de Monestrol I; Gilljam M; Krantz C; McGarry LJ; Banefelt J; Aldven M
Article: PEDIATRIC PULMONOLOGY. 2024;59(11):2967-2975
Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study
Medbo J; Imberg H; Hansen C; Krantz C; de Monestrol I; Svedberg M
Article: JOURNAL OF CYSTIC FIBROSIS. 2024;23(5):815-822
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
Semenchuk J; Naito Y; Charman SC; Carr SB; Cheng SY; Marshall BC; Faro A; Elbert A; Gutierrez HH; Goss CH; Karadag B; Burgel P-R; Colombo C; Salvatore M; Padoan R; Daneau G; Harutyunyan S; Kashirskaya N; Kirwan L; Middleton PG; Ruseckaite R; de Monestrol I; Naehrlich L; Mondejar-Lopez P; Jung A; van Rens J; Bakkeheim E; Orenti A; Ommen DZ-V; da Silva-Filho LVRF; Fernandes FF; Zampoli M; Stephenson AL
Article: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. 2024;18:17534666241254090
Impact of lumacaftor/ivacaftor on the bacterial and fungal respiratory pathogens in cystic fibrosis: a prospective multicenter cohort study in Sweden
Al Shakirchi M; Sorjonen K; Hjelte L; Klingspor L; Bergman P; Ericson P; Svedberg M; Lindberg U; Hansen C; de Monestrol I
Article: JOURNAL OF CYSTIC FIBROSIS. 2023;22(2):263-265
Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators
Colombo C; Ramm GA; Lindblad A; Corti F; Porcaro L; Alghisi F; Asherova I; Evans H; Kashirskaya N; Kondratyeva E; Lewindon PJ; de Monestrol I; Oliver M; Ooi CY; Padoan R; Shankar S; Alicandro G
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2022;88(11):4845-4853
Antibiotic hypersensitivity in cystic fibrosis - Low frequency of anaphylaxis over 16 000 courses
Kowalik A; de Monestrol I; Sorjonen K; Brockow K; Gulen T
Article: JOURNAL OF CYSTIC FIBROSIS. 2022;21(4):e221-e231
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
Carr SB; McClenaghan E; Elbert A; Faro A; Cosgriff R; Abdrakhmanov O; Brownlee K; Burgel P-R; Byrnes CA; Cheng SY; Colombo C; Corvol H; Daneau G; Goss CH; Gulmans V; Gutierrez H; Harutyunyan S; Helmick M; Jung A; Kashirskaya N; McKone E; Melo J; Middleton PG; Mondejar-Lopez P; de Monestrol I; Naehrlich L; Padoan R; Parker M; Pastor-Vivero MD; Rizvi S; Ruseckaite R; Salvatore M; Da Silva-Filho LVRF; Versmessen N; Zampoli M; Marshall BC; Stephenson AL
Article: JOURNAL OF CYSTIC FIBROSIS. 2022;21(2):220-226
Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study
Colombo C; Alicandro G; Oliver M; Lewindon PJ; Ramm GA; Ooi CY; Alghisi F; Kashirskaya N; Kondratyeva E; Corti F; Padoan R; Asherova I; Evans H; de Monestrol I; Strandvik B; Lindblad A
Article: JOURNAL OF FUNGI. 2021;7(11):944
The Effects of Aspergillus fumigatus Colonization on Lung Function in Patients with Cystic Fibrosis
Al Shakirchi M; Sorjonen K; Klingspor L; Bergman P; Hjelte L; de Monestrol I
Article: ERJ OPEN RESEARCH. 2021;7(4):411-2021
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
Jung A; Orenti A; Dunlevy F; Aleksejeva E; Bakkeheim E; Bobrovnichy V; Carr SB; Colombo C; Corvol H; Cosgriff R; Daneau G; Dogru D; Drevinek P; Vukic AD; Fajac I; Fox A; Fustik S; Gulmans V; Harutyunyan S; Hatziagorou E; Kasmi I; Kayserova H; Kondratyeva E; Krivec U; Makukh H; Malakauskas K; McKone EF; Mei-Zahav M; de Monestrol I; Olesen HV; Padoan R; Parulava T; Pastor-Vivero MD; Pereira L; Petrova G; Pfleger A; Pop L; van Rens JG; Rodic M; Schlesser M; Storms V; Turcu O; Wozniacki L; Yiallouros P; Zolin A; Downey DG; Naehrlich L
Article: JOURNAL OF CYSTIC FIBROSIS. 2021;20(4):566-577
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020
Naehrlich L; Orenti A; Dunlevy F; Kasmi I; Harutyunyan S; Pfleger A; Keegan S; Daneau G; Petrova G; Tjesic-Drinkovic D; Yiallouros P; Bilkova A; Olesen HV; Burgel P-R; Parulava T; Diamantea F; Parniczky A; McKone EF; Mei-Zahav M; Salvatore M; Colombo C; Aleksejeva E; Malakauskas K; Schlesser M; Fustik S; Turcu O; Zomer-van Ommen D; Wathne AS; Wozniacki L; Pereira L; Pop L; Kashirskaya N; Rodic M; Kayserova H; Krivecs U; Mondejar-Lopez P; de Monsterol I; Dogru D; Makukh H; Cosgriff R; van Koningsbruggen-Rietschel S; Jung A; Bobrovnichy V; Bambir I; Vukic AD; Drevinek P; Macek MJ; Corvol H; Lemonnier-Videau L; Hatziagorou E; Fletcher G; Padoan R; Gulmans V; Bakkeheim E; Kondratyeva E; Amelina E; Zhekaite E; Simonova O; Pastor-Vivero MD; Lindblad A; Gokdemir Y; Pekcan S; Brownlee K; McClenaghan E; Carr S; Lammertyn E; Zolin A; Fox A; Krasnyk M; Van Rens J
Article: JOURNAL OF CYSTIC FIBROSIS. 2021;20(1):25-30
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study
Bain R; Cosgriff R; Zampoli M; Elbert A; Burgel P-R; Carr SB; Castanos C; Colombo C; Corvol H; Faro A; Goss CH; Gutierrez H; Jung A; Kashirskaya N; Marshall BC; Melo J; Mondejar-Lopez P; Monestrol ID; Naehrlich L; Padoan R; Pastor-Vivero MD; Rizvi S; Salvatore M; Ribeiro Ferreira da Silva Filho LV; Brownlee KG; Haq IJ; Brodlie M
Article: JOURNAL OF CYSTIC FIBROSIS. 2020;19(6):868-871
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
McClenaghan E; Cosgriff R; Brownlee K; Ahern S; Burgel P-R; Byrnes CA; Colombo C; Corvol H; Cheng SY; Daneau G; Elbert A; Faro A; Goss CH; Gulmans V; Gutierrez H; de Monestrol I; Jung A; Justus LN; Kashirskaya N; Marshall BC; McKone E; Middleton PG; Mondejar-Lopez P; Pastor-Vivero MD; Padoan R; Rizvi S; Ruseckaite R; Salvatore M; Stephenson AL; da Silva Filho LVR; Melo J; Zampoli M; Carr SB
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2020;96:663-670
A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function
Al Shakirchi M; Klingspor L; Bergman P; Hjelte L; de Monestrol I
Article: RESPIRATORY CARE. 2018;63(12):1535-1540
Experiences of Individuals Awaiting Lung Transplantation
Skogeland U; de Monestrol I; Godskesen TE
Article: ARCHIVES OF DISEASE IN CHILDHOOD. 2017;102(8):742-747
Effect of allergic bronchopulmonary aspergillosis on FEV₁ in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis
Kaditis AG; Miligkos M; Bossi A; Colombo C; Hatziagorou E; Kashirskaya N; de Monestrol I; Thomas M; Mei-Zahav M; Chrousos G; Zolin A
Article: PAEDIATRIC AND PERINATAL EPIDEMIOLOGY. 2011;25(3):298-305
Age at diagnosis and disease progression of cystic fibrosis in an area without newborn screening
de Monestrol I; Klint A; Sparen P; Hjelte L
Article: ACTA PAEDIATRICA. 2011;100(2):209-215
Parental support for newborn screening for cystic fibrosis
de Monestrol I; Brucefors AB; Sjoberg B; Hjelte L
Article: HUMAN MUTATION. 2009;30(7):1093-1103
Mutations in the Amiloride-Sensitive Epithelial Sodium Channel in Patients With Cystic Fibrosis-Like Disease
Azad AK; Rauh R; Vermeulen F; Jaspers M; Korbmacher J; Boissier B; Bassinet L; Fichou Y; des Georges M; Stanke F; De Boeck K; Dupont L; Balascakova M; Hjelte L; Lebecque P; Radojkovic D; Castellani C; Schwartz M; Stuhrmann M; Schwarz M; Skalicka V; de Monestrol I; Girodon E; Ferec C; Claustres M; Tuemmler B; Cassiman J-J; Korbmacher C; Cuppens H
Article: PEDIATRIC PULMONOLOGY. 2002;33(6):483-491
Predictors of deterioration of lung function in cystic fibrosis
Schaedel C; de Monestrol I; Hjelte L; Johannesson M; Kornfält R; Lindblad A; Strandvik B; Wahlgren L; Holmberg L
Article: CLINICAL GENETICS. 1999;56(4):318-322
Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in Sweden
Schaedel C; Hjelte L; de Monestrol I; Johannesson M; Kollberg H; Kornfält R; Holmberg L
Show more

All other publications

Review: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2024;416(26):5565-5577
Development and clinical implementation of an LC-HRMS method for ivacaftor, lumacaftor, tezacaftor and elexacaftor in human plasma and breast milk.
Hansson AB; Wadström H; Eliasson E; Al Shakirchi M; de Monestrol I; Barclay V
Letter: EUROPEAN RESPIRATORY JOURNAL. 2017;49(1):1600686
Does newborn screening influence the young cystic fibrosis cohort included in national registries?
De Boeck K; Munck A; de Monestrol I; Gulmans V; Lemonnier L; Middleton PG; Wanyama S; Thomas M
Doctoral thesis: 2011
Studies as a basis for a possible introduction of newborn screening for cystic fibrosis in Sweden
de Monestrol I
Review: JOURNAL OF CYSTIC FIBROSIS. 2009;8(3):153-173
European best practice guidelines for cystic fibrosis neonatal screening
Castellani C; Southern KW; Brownlee K; Roelse JD; Duff A; Farrell M; Mehta A; Munck A; Pollitt R; Sermet-Gaudelus I; Wilcken B; Ballmann M; Corbetta C; de Monestrol I; Farrell P; Feilcke M; Ferec C; Gartner S; Gaskin K; Hammermann J; Kashirskaya N; Loeber G; Macek MJ; Mehta G; Reiman A; Rizzotti P; Sammon A; Sands D; Smyth A; Sommerburg O; Torresani T; Travert G; Vernooij A; Elborn S

Employments

Affiliated to Research, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2023-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2011
University Medical Degree, Karolinska Institutet, 1991

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI